SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-216944
Filing Date
2019-08-08
Accepted
2019-08-08 16:48:04
Documents
19
Period of Report
2019-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d778676d8k.htm   iXBRL 8-K 42711
2 EX-1.1 d778676dex11.htm EX-1.1 190749
3 EX-3.1 d778676dex31.htm EX-3.1 82236
4 EX-4.1 d778676dex41.htm EX-4.1 102911
5 EX-5.1 d778676dex51.htm EX-5.1 8861
6 EX-99.1 d778676dex991.htm EX-99.1 6483
7 EX-99.2 d778676dex992.htm EX-99.2 7718
11 GRAPHIC g778676g0808113925449.jpg GRAPHIC 2231
  Complete submission text file 0001193125-19-216944.txt   686869

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA dvax-20190807.xsd EX-101.SCH 3064
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20190807_lab.xml EX-101.LAB 18136
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20190807_pre.xml EX-101.PRE 11403
12 EXTRACTED XBRL INSTANCE DOCUMENT d778676d8k_htm.xml XML 3232
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 191010237
SIC: 2834 Pharmaceutical Preparations